These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9278290)

  • 21. How to extinguish lymphocyte activation, immunotyrosine-based inhibition motif (ITIM)-bearing molecules a solution?
    Blery M; Vivier E
    Clin Chem Lab Med; 1999 Mar; 37(3):187-91. PubMed ID: 10353459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling.
    Barrow AD; Trowsdale J
    Eur J Immunol; 2006 Jul; 36(7):1646-53. PubMed ID: 16783855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Roles of protein tyrosine kinases in activation, proliferation and apoptosis of immuno-hematopoietic cells].
    Minami Y; Sada K; Oishi I; Yamamura H
    Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1666-72. PubMed ID: 8890621
    [No Abstract]   [Full Text] [Related]  

  • 24. Signalling an interest.
    Yu H; Schreiber SL
    Nat Struct Biol; 1994 Jul; 1(7):417-20. PubMed ID: 7545075
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells.
    Gergely J; Pecht I; Sármay G
    Immunol Lett; 1999 May; 68(1):3-15. PubMed ID: 10397150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoreceptor tyrosine-based inhibition motifs.
    Vivier E; Daëron M
    Immunol Today; 1997 Jun; 18(6):286-91. PubMed ID: 9190115
    [No Abstract]   [Full Text] [Related]  

  • 27. Structure and function of the protein tyrosine kinases.
    Wilks AF
    Prog Growth Factor Res; 1990; 2(2):97-111. PubMed ID: 1966559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine receptor signal transduction mechanisms in immuno-hematopoietic cells.
    Chiarugi V; Dello Sbarba P; Magnelli L; Chiarugi P; Pacini S; Ruggiero M
    Tumori; 1993 Apr; 79(2):92-9. PubMed ID: 8394037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction to cytokine receptors: structure and signal transduction.
    Foxwell B; Barrett K
    Int Rev Exp Pathol; 1993; 34 Pt B():105-21. PubMed ID: 8384609
    [No Abstract]   [Full Text] [Related]  

  • 30. Growth factor signaling by receptor tyrosine kinases.
    Schlessinger J; Ullrich A
    Neuron; 1992 Sep; 9(3):383-91. PubMed ID: 1326293
    [No Abstract]   [Full Text] [Related]  

  • 31. Human cytokine receptors.
    Dower SK; Smith CA; Park LS
    J Clin Immunol; 1990 Nov; 10(6):289-99. PubMed ID: 1964693
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell surface receptors.
    Deller MC; Yvonne Jones E
    Curr Opin Struct Biol; 2000 Apr; 10(2):213-9. PubMed ID: 10753817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune and hematopoietic cell regulation: cytokines and their receptors.
    Taga T; Kishimoto T
    Curr Opin Cell Biol; 1990 Apr; 2(2):174-80. PubMed ID: 2163655
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytokines in the nineties.
    Smith KA
    Eur Cytokine Netw; 1990; 1(1):7-13. PubMed ID: 2102363
    [No Abstract]   [Full Text] [Related]  

  • 35. Biology of immunoreceptor tyrosine-based inhibition motif-bearing molecules.
    Daëron M; Vivier E
    Curr Top Microbiol Immunol; 1999; 244():1-12. PubMed ID: 10453645
    [No Abstract]   [Full Text] [Related]  

  • 36. Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.
    Slee JB; Christian AJ; Levy RJ; Stachelek SJ
    Polymers (Basel); 2014 Sep; 6(10):2526-2551. PubMed ID: 25705515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular structures and functional properties of cell-surface receptors].
    Yokoyama S
    Nihon Rinsho; 2002 Feb; 60(2):218-20. PubMed ID: 11857905
    [No Abstract]   [Full Text] [Related]  

  • 38. Validation of agent-based models of surface receptor oligomerisation.
    Clark JC; Watson SP; Owen DM
    Trends Pharmacol Sci; 2023 Oct; 44(10):643-646. PubMed ID: 37507263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ITIMs: episode 1 of the inhibitory saga.
    Vivier E
    Nat Rev Immunol; 2018 Jan; 18(1):4. PubMed ID: 29176731
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for Extensive Duplication and Subfunctionalization of
    Matos MC; Pinheiro A; Davis RS; Esteves PJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.